Contribute Try STAT+ Today

The development of safe, effective, and innovative biologic medicines is one of modern medicine’s far-reaching achievements. From cancer and colitis to rheumatoid arthritis, biologics have transformed many severe diseases into treatable conditions for millions of people.

Unlike so-called small-molecule drugs, like aspirin or a cholesterol-lowering statin, which are normally developed by synthesizing chemicals with well-defined structures, biologics are derived from complex living organisms. Current biologics are administered either by infusion under a doctor’s supervision or by injection, which can be done in a doctor’s office or at home.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.